REG - Yooma Wellness Inc. - Significant acquisition of Vitality CBD

Yooma WellnessAnnouncement

20/08/2021 07:05

RNS Number : 2468J
  
Yooma Wellness Inc.
  
20 August 2021
  
 



20 August 2021
Yooma Wellness Inc.
("Yooma" or the "Company" or the "Group")
 
Significant acquisition of Vitality CBD
Yooma acquires award winning and market-leader in CBD products in the UK 
Exponential exposure to retail market via Boots, Tesco, Asda and Lloyds Pharmacy
Yooma Wellness Inc. (CSE:YOOM; AQSE:YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce it has completed the acquisition of Birmingham-based Vitality CBD Limited ("Vitality"), a UK-market-leading CBD company, for a total consideration of up to £10.2 million (the "acquisition"), via the Company's wholly owned subsidiary, Yooma Europe Limited.  
The acquisition adds a significant source of recurring revenue to Yooma and its subsidiaries, through Vitality's presence at mainstream retail outlets such as Boots, Tesco, Asda and Lloyds Pharmacy, as well as expanding the Group's target customer base and distribution network for its existing European-focused brands, including the MYO plant nutrition platform. 
In the six-month period to 30 June 2021, Vitality had gross turnover of £1.6 million and EBITDA of approximately £300,000. There are significant synergies to be had and by working with the Yooma management team, Vitality will focus on growing revenue and margin in the latter half of 2021 as well as expanding distribution to other European and International markets.  
This is the first acquisition since it completed the dual-listing of its shares on the AQSE Growth Market in London on 10 August 2021 and is part of Yooma's buy-and-build strategy. 
Lorne Abony, Chairman of Yooma, commented: "Completing the acquisition of Vitality is the first step of the strategic plan the Company outlined to investors at the time of our UK financing and dual-listing - to buy and build companies globally, focused on materially increasing the Company's top-line revenue, leveraging the Group's integrated supply chain to drive margin growth, and expanding distribution for the existing product portfolio. This acquisition will help accelerate our growth by exporting these branded products to other Yooma jurisdictions and integrating with our MYO Plant Nutrition operations and distribution.  Vitality is a market leader in the UK with presence in major retail outlets such as Boots, Tesco, Asda and Lloyds Pharmacy and we look forward to working with the team at Vitality."
 
Nikhil Nathwani, Co-founder and Managing Director commented on the acquisition: "The whole Vitality CBD team are excited to be joining the Yooma group. CBD is a growing industry not only in the UK but globally, and the acquisition positions us nicely to be able to continue to expand and grow the business."
 
Details of the Acquisition
Under the terms of a sale and purchase agreement, the Company has acquired 100% of the issued shares of Vitality for total consideration of up to £10.2 million (the "Consideration") comprising:
Ø  £4 million cash at closing ("Cash Consideration") subject to agreed working capital adjustments (Vitality being acquired on a cash-free / debt-free basis);
 
Ø  7,706,422 new common shares of the Company ("Consideration Shares") representing £4.2 million issued at an implied price of £0.545 per share; and
 
Ø  up to £2 million of cash or share-based consideration, at the Company's option, subject to the achievement of revenue milestones by Vitality for the financial year 2022 as set out below:




Value of the 2022 Revenue


Value of the Deferred Consideration due to the Sellers




Greater than £5 million but less than £6 million


£500,000




£6 million or more, but less than £7 million


£1 million




£7 million but less than £8 million


£1.5 million




£8 million or more


£2 million




 
Cash consideration for the acquisition will be funded from the Company's existing cash.
100% of the Consideration Shares are subject to a lock-in, with 25% of the Consideration Shares being released from the lock-in on each of the 10-month, 16-month, 22-month and 28-month anniversaries of completion. 
The Company has received customary warranties and indemnities in relation to the business and operations, assets, trading and financial affairs of Vitality (with related tax covenant and warranties).
The current senior management team at Vitality have been retained and will continue to operate the business day-to-day as the Company focuses on integration and expansion.
 
Admission of Consideration Shares and Total Voting Rights
Application will be made for the Consideration Shares, which will rank pari passu with the existing common shares in issue, to be admitted to trading on the AQSE Growth Market ("Admission"). Dealings are expected to commence on or around 23 August 2021.
Following Admission, Nikhil Nathwani, the largest shareholder of Vitality prior to the acquisition by the Company, will hold a total of 4,623,852 common shares of the Company, representing 4.74% of the Company's issued common shares.
The Company's total issued and voting share capital upon Admission of the Consideration Shares will consist of 97,497,707 common shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company. 
About Vitality CBD Limited
Vitality CBD is the most widely stocked brand of CBD in the UK with products distributed in national retailers such as Boots, Tesco, ASDA and Lloyds Pharmacy. Vitality CBD is also prominent on E-commerce retailers such as Amazon, Very & Ocado. The Vitality CBD product portfolio has over 60 SKUs including oils and sprays in a wide range of flavours and strengths, edibles, and a specially developed and formulated range of CBD skin care cosmetic products.
 
About Yooma Wellness Inc.
Yooma's mission is to build a vertically-integrated global leader in the manufacturing, marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients. The company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United States, United Kingdom, France and Japan. Learn more at www.yooma.ca.
 
- Ends -




 
For further information, please contact:


 




Yooma Wellness Inc.
Jordan Greenberg, CEO
jgreenberg@yooma.ca
 


Via Buchanan
Tel:+44 (0) 20 7466 5000
 




AQSE Corporate Adviser:
Peterhouse Capital Limited
Guy Miller / Mark Anwyl
 


Tel: +44 (0) 20 7469 0930
Tel: +44 (0) 7990 139 093




Media Enquiries (Canada):
Michael Bancroft
michaelbancroft@globalive.com
 


 




Media Enquiries (UK / Europe):
Buchanan
Henry Harrison-Topham / Jamie Hooper
Ariadna Peretz / George Beale
yooma@buchanan.uk.com
 


Tel: +44 (0) 20 7466 5000
www.buchanan.uk.com




 
Non IFRS Measures
 
In this press release reference is made to EBITDA, which does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. Vitality defines EBITDA as earnings before interest, tax, depreciation or amortization. This measure is provided as information complementary to standard IFRS measures such as revenue and net profit/loss by providing the reader with a further understanding of operational results from the perspective of management.  This measure should not be considered in isolation or as an alternative or substitute to measures prepared in accordance with IFRS (such as net profit/loss). 
 
Notice regarding Forward Looking Statements
All information included in this press release, including any information as to future financial or operating performance and other statements of Yooma that express management's expectations or estimates of future performance or activities, other than statements of historical fact, constitute forward-looking information or forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable securities laws and are based on expectations, estimates and projections as of the date hereof. Forward-looking statements are included for the purpose of providing information about management's current expectations and plans relating to the future. Wherever possible, words such as "will", "intend", "future", "anticipate", "potential", "plan", "subject to", "recurring", increasing", "leveraging", "expanding", "continue to" or the negative of these words or other variations thereof, have been used to identify such forward-looking information. Specific forward-looking statements include, without limitation, all disclosure regarding future results of operations, economic conditions and anticipated courses of action, including statements about Vitality's revenues and margin, the achievement by Vitality of revenue milestones, the Company's strategic plan, the admission of the Consideration Shares to trading on the AQSE and the effect of the foregoing matters on the growth of the Company.
 
There are many risks and uncertainties that may affect forward-looking statements including, among others, regulatory risk in each jurisdiction in which Yooma does or intends to operate; the uncertainties, effects of and responses to the COVID-19 pandemic; reliance on licenses; competition; dependence on senior management and key personnel; general business risk and liability; regulation of the CBD industry; changes in laws, regulations and guidelines; compliance with laws; limited operating history; unfavourable publicity or consumer perception; product liability; risks related to intellectual property; product recalls; difficulties with forecasts; management of growth; litigation; the possibility that Vitality will be unable to achieve its historical revenues, margins or growth; difficulties integrating Vitality into the Group; delays or issues obtaining approval for Admission; claims for indemnity under the transaction documents for the acquisition; lack of available acquisition opportunities or an inability to take advantage of those opportunities; changes in market interest in CBD products; and other matters which are beyond the control of Yooma. Although the forward-looking statements contained herein reflect management's current beliefs and reasonable assumptions based upon information available to management as of the date hereof, Yooma cannot be certain that actual results will be consistent with such forward-looking information. Yooma cautions you not to place undue reliance upon any such forward-looking statements. Yooma disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of Yooma.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NEXGPUMURUPGPPB